AU3964499A - Agouti-related protein analogs and methods of use - Google Patents

Agouti-related protein analogs and methods of use

Info

Publication number
AU3964499A
AU3964499A AU39644/99A AU3964499A AU3964499A AU 3964499 A AU3964499 A AU 3964499A AU 39644/99 A AU39644/99 A AU 39644/99A AU 3964499 A AU3964499 A AU 3964499A AU 3964499 A AU3964499 A AU 3964499A
Authority
AU
Australia
Prior art keywords
agouti
methods
related protein
protein analogs
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39644/99A
Inventor
Ira Gantz
Stephen B.H. Kent
Darren A. Thompson
Jill Wilken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gryphon Therapeutics Inc
Original Assignee
Gryphon Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gryphon Sciences filed Critical Gryphon Sciences
Publication of AU3964499A publication Critical patent/AU3964499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU39644/99A 1998-03-30 1999-03-30 Agouti-related protein analogs and methods of use Abandoned AU3964499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7995798P 1998-03-30 1998-03-30
US60079957 1998-03-30
PCT/US1999/006968 WO1999050295A2 (en) 1998-03-30 1999-03-30 Agouti-related protein analogs and methods of use

Publications (1)

Publication Number Publication Date
AU3964499A true AU3964499A (en) 1999-10-18

Family

ID=22153903

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39644/99A Abandoned AU3964499A (en) 1998-03-30 1999-03-30 Agouti-related protein analogs and methods of use

Country Status (2)

Country Link
AU (1) AU3964499A (en)
WO (1) WO1999050295A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030808A1 (en) * 1999-10-27 2001-05-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor-ligand binding
EP1125579A3 (en) 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
AU2001261363A1 (en) * 2000-05-09 2001-11-20 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
WO2003075742A2 (en) * 2002-03-05 2003-09-18 Merck & Co., Inc. Biomarker for efficacy of appetite suppressant drugs
CA2562075C (en) 2004-04-20 2012-08-14 Transtech Pharma, Inc. Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
US20110160128A1 (en) * 2008-03-28 2011-06-30 Qingyu Wu Corin for Treating Obesity and Diabetes
CA2731442A1 (en) 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
US5932779A (en) * 1996-06-10 1999-08-03 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight

Also Published As

Publication number Publication date
WO1999050295A2 (en) 1999-10-07
WO1999050295A3 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
AU6030398A (en) Human proteins
AU5721798A (en) Human mage-like protein
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
EP1071706A4 (en) Rapidly degrading gfp-fusion proteins and methods of use
AU3068699A (en) Skin equivalent and methods of forming and using same
AU6046998A (en) Method of measuring physiological function
EP1033994A4 (en) Methods of preparation of bioginkgo
AU3789399A (en) Indolicidin analogs and methods of using same
AU3902297A (en) Two human nsp-like proteins
AU6585498A (en) Novel uncoupling protein and methods of use
AU4992299A (en) Uncoupling protein 4 (ucp-4) and methods of use
AU4480697A (en) Human nm23-like protein
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU3118297A (en) Sok-1 and methods of use
AU4202699A (en) Human socs proteins
AU3964499A (en) Agouti-related protein analogs and methods of use
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU5475199A (en) Human chordin-related proteins and polynucleotides encoding them
AU1914400A (en) Human hydrolase proteins
AU9017598A (en) Human frezzled-like protein
EP1140121A4 (en) Cryogranulation of activated protein c
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use
AU8747098A (en) Human galectin-9-like proteins and cdnas encoding these proteins
AU9756898A (en) Human prostaglandin receptors and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase